Tissue-specific differentiation potency of mesenchymal stromal cells from perinatal tissues

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kwon, Ahlm ^a   Kim, Yonggoo ^a,b   Kim, Myungshin ^a,b   Kim, Jiyeon ^a   Choi, Hayoung ^a   Jekarl, Dong Wook ^a,b   Lee, Seungok ^a,b   Kim, Jung Min ^c   Shin, Jong Chul ^b   Park, In Yang ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Daejeon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CDKN2A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2C; LIPOCORTIN 5;

AMNION; CARDIAC MUSCLE CELL; CELL AGING; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORION; CYTOLOGY; EMBRYOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; HUMAN; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; MORPHOGENESIS; NERVE CELL; PREGNANCY; TISSUE MICROARRAY; UMBILICAL CORD; UPREGULATION;

AMNION; ANNEXIN A5; BETA-GALACTOSIDASE; CELL AGING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORION; CYCLIN-DEPENDENT KINASE INHIBITOR P18; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MORPHOGENESIS; MYOCYTES, CARDIAC; NEURONS; PREGNANCY; TISSUE ARRAY ANALYSIS; UMBILICAL CORD; UP-REGULATION;

EID: 84962656834     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23544     Document Type: Article

References (37)

1. Parolini, O., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (Dayton, Ohio) 26, 300-311, doi: 10.1634/stemcells.2007-0594 (2008).
2. Bačenkova, D., Rosocha, J., Tothova, T., Rosocha, L., & Sarissky, M. Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells. Cytotherapy 13, 1047-1056, doi: 10.3109/14653249.2011.592522 (2011).
3. Carvalho, M. M., Teixeira, F. G., Reis, R. L., Sousa, N., & Salgado, A. J. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 6, 221-228 (2011).
4. Anzalone, R., et al. Whartons jelly mesenchymal stem lcells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev 7, 342-363, doi: 10.1007/s12015-010-9196-4 (2011).
5. Nekanti, U., et al. Long-Term expansion and pluripotent marker array analysis of Whartons jelly-Derived mesenchymal stem cells. Stem Cells Dev 19, 117-130, doi: 10.1089/scd.2009.0177 (2010).
6. Bai, J., et al. Comparison of human amniotic fluid-Derived and umbilical cord Whartons Jelly-Derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity. J Geriatr Cardiol 9, 166-171, doi: 10.3724/sp.j.1263.2011. 12091 (2012).
7. Soncini, M., et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1, 296-305, doi: 10.1002/term.40 (2007).
8. Yamahara, K., et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorionderived mesenchymal stem cells. PloS one 9, e88319, doi: 10.1371/journal.pone.0088319 (2014).
9. Kim, M. J., et al. Human chorionic-plate-Derived mesenchymal stem cells and Whartons jelly-Derived mesenchymal stem cells: a comparative analysis of their potential as placenta-Derived stem cells. Cell Tissue Res 346, 53-64, doi: 10.1007/ s00441-011-1249-8 (2011).
10. Dominici, M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317, doi: 10.1080/14653240600855905 (2006).
11. Rothman, R. B., et al. Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications. Circulation 102, 2836-2841, doi: 10.1161/01.cir.102.23.2836 (2000).
12. Kaumann, A. J., & Levy, F. O. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmaco Ther 111, 674-706 (2006).
13. Coronel, M. F., Musolino, P. L., Brumovsky, P. R., Hokfelt, T., & Villar, M. J. Bone marrow stromal cells attenuate injury-induced changes in galanin, NPY and NPY Y1-receptor expression after a sciatic nerve constriction. Neuropeptides 43, 125-132, doi: 10.1016/j.npep.2008.12.003 (2009).
14. Rus CiucǍ, D., SoritǍu, O., Susman, S., Pop, V. I., & Mihu, C. M. Isolation and characterization of chorionic mesenchyal stem cells from the placenta. Rom J Morphol Embryol 52, 803-808 (2011).
15. Oliveira, M. S., & Barreto-Filho, J. B. Placental-Derived stem cells: Culture, differentiation and challenges. World J Stem Cells 7, 769-775, doi: 10.4252/wjsc.v7.i4. 769 (2015).
16. Wegmeyer, H., et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev 22, 2606-2618, doi: 10.1089/scd.2013.0016 (2013).
17. Peltzer, J., et al. Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use. Stem Cells Dev 24, 329-344, doi: 10.1089/scd.2014.0327 (2015).
18. Jaramillo-Ferrada, P. A., Wolvetang, E. J., & Cooper-White, J. J. Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-Term placenta and bone marrow. J Cell Physiol 227, 3234-3242, doi: 10.1002/ jcp.24014 (2012).
19. Stubbendorff, M., et al. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. Stem Cells Dev 22, 2619-2629, doi: 10.1089/scd.2013.0043 (2013).
20. Sabapathy, V., Ravi, S., Srivastava, V., Srivastava, A., & Kumar, S. Long-Term cultured human term placenta-Derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int 2012, 174328, doi: 10.1155/2012/174328 (2012).
21. Lee, Y., et al. Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-Derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem 114, 79-88, doi: 10.1002/jcb.24303 (2013).
22. Suphanantachat, S., et al. A role for c-Kit in the maintenance of undifferentiated human mesenchymal stromal cells. Biomaterials 35, 3618-3626, doi: 10.1016/ j.biomaterials.2014.01.031 (2014).
23. Fanchin, R., Gallot, V., Rouas-Freiss, N., Frydman, R., & Carosella, E. D. Implication of HLA-G in human embryo implantation. Hum Immunol 68, 259-263, doi: 10.1016/ j.humimm.2006.11.002 (2007).
24. Naji, A., et al. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells (Dayton, Ohio) 31, 2296-2303, doi: 10.1002/stem.1494 (2013).
25. Shibata, K. R., et al. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells (Dayton, Ohio) 25, 2371-2382, doi: 10.1634/ stemcells.2007-0225 (2007).
26. Varrault, A., et al. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc Nati Acad Sci USA 95, 8835-8840 (1998).
27. Nebigil, C. G., et al. Serotonin 2B receptor is required for heart development. Proc Nati Acad Sci USA 97, 9508-9513 (2000).
28. Zhou, J., et al. Neural cell injury microenvironment induces neural differentiation of human umbilical cord mesenchymal stem cells. Neural Regen Res 7, 2689-2697, doi: 10.3969/j.issn.1673-5374.2012.34.006 (2012).
29. Lesurtel, M., et al. Platelet-Derived serotonin mediates liver regeneration. Science (New York, N.Y.) 312, 104-107, doi: 10.1126/ science.1123842 (2006).
30. Okamoto, K., et al. Working cardiomyocytes exhibiting plateau action potentials from human placenta-Derived extraembryonic mesodermal cells. Exp Cell Res 313, 2550-2562, doi: http://dx.doi.org/10.1016/j.yexcr.2007.04.028 (2007).
31. Yamada, Y., Sakurada, K., Takeda, Y., Gojo, S., & Umezawa, A. Single-cell-Derived mesenchymal stem cells overexpressing Csx/ Nkx2.5 and GATA4 undergo the stochastic cardiomyogenic fate and behave like transient amplifying cells. Exp Cell Res 313, 698-706, doi: 10.1016/j.yexcr.2006.11.012 (2007).
32. Frausin, S., et al. Whartons jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem 117, 329-338, doi: 10.1016/j.acthis. 2015.02.005 (2015).
33. Zhang, L., et al. In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Whartons jelly, into choline acetyltransferase (ChAT)-positive cells. Int J Dev Neurosci 30, 471-477, doi: 10.1016/j.ijdevneu. 2012.05.006 (2012).
34. Mitchell, K. E., et al. Matrix cells from Whartons jelly form neurons and glia. Stem Cells (Dayton, Ohio) 21, 50-60, doi: 10.1634/ stemcells.21-1-50 (2003).
35. Fu, Y. S., et al. Conversion of human umbilical cord mesenchymal stem cells in Whartons jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells (Dayton, Ohio) 24, 115-124, doi: 10.1634/stemcells.2005-0053 (2006).
36. Taghizadeh, R. R., Cetrulo, K. J., & Cetrulo, C. L. Whartons Jelly stem cells: future clinical applications. Placenta 32 Suppl 4, S311-315, doi: 10.1016/j.placenta. 2011.06.010 (2011).
37. Koo, B. K., et al. Isolation and characterization of chorionic mesenchymal stromal cells from human full term placenta. J Korean Med Sci 27, 857-863, doi: 10.3346/ jkms.2012.27.8.857 (2012).